Dealing with the healthcare challenges of the future is one of the biggest issues facing the current generation. Improvements in sanitation, vaccination and infection control in the last century mean that people today are living longer. However, chronic neurological and immunological problems, the causes of which are still unclear, are tempering these successes. Inflammatory conditions such as lupus and rheumatoid arthritis and neurological disorders such as Parkinson’s and epilepsy are where the new battle lines are being drawn. UCB is one of the companies at the forefront of efforts to find treatments and cures. European Business spoke to the company’s Area Head Central Europe Peter Mitterhofer about its latest beakthroughs and how modern developments such as Big Data and digitalization are affecting the market.